(Q40198109)

English

Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.

scientific article published on 11 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

author name string

Kurbanov BM

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Fecker LF

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Geilen CC

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sterry W

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Eberle J

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

11 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3364-3377

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210134

0 references

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Apoptosis-based therapies and drug targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Death receptors and melanoma resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

NF-kappaB: linking inflammation and immunity to cancer development and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Apo2L/TRAIL and its death and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

NF-kappaB in cancer--a friend turned foe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Apoptosis and melanoma chemoresistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

TRAIL and apoptosis induction by TNF-family death receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

21 January 2018

IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

7 January 2021

based on heuristic

inferred from DOI database lookup

PI-3K/Akt and NF-?B/I?B? pathways are activated in Jurkat T cells in response to TRAIL treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210134

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210134

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40198109&oldid=1667466917"